Literature DB >> 15034841

Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofungin.

Miguel Goicoechea, Joshua Fierer, Scott Johns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034841     DOI: 10.1086/382082

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

2.  Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.

Authors:  Philipp Lenz; Franziska Eckelskemper; Thomas Erichsen; Tim Lankisch; Alexander Dechêne; Gabriele Lubritz; Frank Lenze; Torsten Beyna; Hansjörg Ullerich; Andre Schmedt; Dirk Domagk
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Abdominal candidiasis is a hidden reservoir of echinocandin resistance.

Authors:  Ryan K Shields; M Hong Nguyen; Ellen G Press; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

4.  Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.

Authors:  Gwénolé Prigent; Nawel Aït-Ammar; Eric Levesque; Arnaud Fekkar; Jean-Marc Costa; Sarra El Anbassi; Françoise Foulet; Christophe Duvoux; Jean-Claude Merle; Eric Dannaoui; Françoise Botterel
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Encapsulation of Antifungals in Micelles Protects Candida albicans during Gall-Bladder Infection.

Authors:  Shih-Hung Hsieh; Sascha Brunke; Matthias Brock
Journal:  Front Microbiol       Date:  2017-02-01       Impact factor: 5.640

6.  Comparison of echinocandin antifungals.

Authors:  Gregory Eschenauer; Daryl D Depestel; Peggy L Carver
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.